Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
Nojiri K, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Yoneda M, Yamamoto N, Takei Y, Nobori T, Ito M. Nojiri K, et al. Among authors: ogura s. Int J Oncol. 2013 Jan;42(1):101-8. doi: 10.3892/ijo.2012.1676. Epub 2012 Oct 24. Int J Oncol. 2013. PMID: 23123700
Sarcomatous hepatocellular carcinoma with remittent fever.
Inagaki Y, Sugimoto K, Shiraki K, Yoshizawa N, Tameda M, Ogura S, Yoneda M, Takei Y, Fuke H, Hashimoto A, Yamamoto N, Shimizu A. Inagaki Y, et al. Among authors: ogura s. Intern Med. 2012;51(21):3025-9. doi: 10.2169/internalmedicine.51.7421. Epub 2012 Nov 1. Intern Med. 2012. PMID: 23124144 Free article.
Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.
Beppu T, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Nojiri K, Yoneda M, Fuke H, Yamamoto N, Takei Y, Fujimori M, Hasegawa T, Yamanaka T, Uraki J, Kashima M, Takaki H, Nakatsuka A, Yamakado K, Takeda K. Beppu T, et al. Among authors: ogura s. Anticancer Res. 2012 Nov;32(11):4923-30. Anticancer Res. 2012. PMID: 23155261
The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Kusagawa S, Ogura S, Tanaka J, Yoneda M, Yamamoto N, Okano H, Takei Y, Ito M, Kasai C, Inoue H, Takase K. Nojiri K, et al. Among authors: ogura s. Oncol Rep. 2013 May;29(5):1737-43. doi: 10.3892/or.2013.2322. Epub 2013 Mar 4. Oncol Rep. 2013. PMID: 23467704
Resveratrol sensitizes HepG2 cells to TRAIL-induced apoptosis.
Tameda M, Sugimoto K, Shiraki K, Inagaki Y, Ogura S, Kasai C, Yoneda M, Okamoto R, Yamamoto N, Takei Y, Ito M, Nobori T. Tameda M, et al. Among authors: ogura s. Anticancer Drugs. 2014 Oct;25(9):1028-34. doi: 10.1097/CAD.0000000000000128. Anticancer Drugs. 2014. PMID: 24892721
568 results